Catherine Ybarra: "That's when we started looking into aerosolized vaccines."

"They're developing vaccines that would essentially act like a live virus where it could basically replicate itself into new hosts. And so the idea is that we know that viruses evolve and change, but our vaccines are static. So they wanted to create vaccines that would evolve and change."

"And when we went and we looked at the stated purposes behind trying to implement the transmissible vaccines, they state in their research that part of it is overcoming the issue of noncompliance. The anti-vaxxers. Right. Or the vaccine hesitant."